Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma (MERGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03439709
Recruitment Status : Not yet recruiting
First Posted : February 20, 2018
Last Update Posted : March 1, 2018
Sponsor:
Information provided by (Responsible Party):
Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 30, 2022
Estimated Study Completion Date : December 31, 2022
Publications: